CBD Marketing Agency and Digital Strategy for Cannabis and Telehealth Brands

A CBD marketing agency needs a different playbook because the standard DTC growth loop (pixel everything, optimize to purchase, scale the winners) collides with platform policy and privacy rules, and the same is true for cannabis and telehealth. Brands in these categories face some mix of four constraints:

• Ad policy limits. Meta and Google restrict CBD, cannabis and prescription-drug advertising, and some categories require third-party certification, such as LegitScript, before ads run.
• Data limits. Ad platforms restrict the health-related data advertisers may send, and Meta has added limits on the data and events some health and wellness advertisers can use for optimization.
• Regulatory exposure. Telehealth brands may handle protected health information, and regulators including the HHS Office for Civil Rights and the FTC have addressed health data that reaches ad platforms through tracking tools.
• Channel gaps. Many cannabis businesses cannot buy paid social or search at all, and SMS carriers restrict cannabis messaging.

Platform policies change often. Operator Intelligence builds to each platform's current published policy at the time of the work, documents the assumptions and rechecks them. None of this is legal advice: every brand in these categories should have qualified counsel review its tracking, claims and creative.

No setting makes the Meta pixel HIPAA compliant on its own. Meta's business tools terms prohibit sending sensitive health information, and ad platforms are generally not positioned as HIPAA business associates. For a telehealth brand, the real question is architecture: what data leaves your site, through which systems, under which agreements, and whether anything reaching Meta reveals a person's health.

A privacy-conscious setup usually includes:

• A server-side layer between your site and ad platforms, on infrastructure or a vendor your counsel approves (some brands require a vendor that will sign a business associate agreement).
• An allowlist of generic event names and parameters, with conditions, treatments, intake answers, URL paths and query strings stripped.
• Consent gating and written data-minimization rules.
• Regular QA in Meta Events Manager to confirm exactly what arrives.

Whether your brand is a covered entity or business associate, and what that requires, is a question for healthcare counsel. We implement the architecture they approve.

A creative system for a telehealth or GLP-1 brand is a repeatable way to produce many ad concepts that are varied enough for Meta's delivery system and safe enough to clear review. Our approach has four parts:

• A claims library: approved claims, required disclosures and phrases to avoid, maintained with the brand's medical and legal reviewers.
• Policy-aware concept archetypes: how the service works, provider credibility, access and pricing transparency, and patient education, without before-and-after imagery, promised outcomes or copy that implies knowledge of the viewer's health.
• Agent pre-screening: drafts are checked against the claims library and current platform health policies before a human sees them, the same score-before-spend pattern as the creative analysis tool we built for &LIVY.
• Human and counsel review: nothing launches without sign-off from the people accountable for compliance.

Claims about GLP-1 medications, including compounded versions, draw particular scrutiny from regulators and platforms, which is why the claims library comes first.